EGFR and cancer: Consistent with this notion is our data showing that EGFR was activated by MUC1 in PTX-resistant cancer cells and more importantly, MUC1 inhibition resulted in diminished activity of EGFR and reduced expression of ABCB1 leading to reversal of PTX resistance.